Related references
Note: Only part of the references are listed.Mitophagy and Neuroprotection
Guofeng Lou et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Therapeutic modulation of autophagy: which disease comes first?
Maria Chiara Maiuri et al.
CELL DEATH AND DIFFERENTIATION (2019)
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
Chandrasekaran Padmapriyadarsini et al.
BMJ OPEN (2019)
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Aaron R. Hansen et al.
ONCOLOGIST (2019)
Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)study protocol for a randomized controlled trial
Miranka Wirth et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
(De)glutamylation and cell death in Leishmania parasites
Louise Basmaciyan et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer A Phase 2 Randomized Clinical Trial
Thomas B. Karasic et al.
JAMA ONCOLOGY (2019)
Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells
Yan Tang et al.
CHEST (2019)
Miltefosine increases macrophage cholesterol release and inhibits NLRP3-inflammasome assembly and IL-1β release
Amanda J. Iacano et al.
SCIENTIFIC REPORTS (2019)
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
Jessica Mandrioli et al.
BMJ OPEN (2019)
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
Angel Arnaout et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
Janice M. Mehnert et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
Philip A. Philip et al.
FUTURE ONCOLOGY (2019)
Autophagy, cancer and angiogenesis: where is the link?
Bahareh Kardideh et al.
CELL AND BIOSCIENCE (2019)
Alkylphospholipids are Signal Transduction Modulators with Potential for Anticancer Therapy
Ferda Kaleagasioglu et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
ABT-737 and erufosine combination against castration-resistant prostate cancer: a promising but cell-type specific response associated with the modulation of anti-apoptotic signaling
Ezgi Avsar Abdik et al.
ANTI-CANCER DRUGS (2019)
Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
Marta Perez-Hernandez et al.
CANCERS (2019)
Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma
Naomi B. Haas et al.
CLINICAL CANCER RESEARCH (2019)
Optineurin downregulation induces endoplasmic reticulum stress, chaperone-mediated autophagy, and apoptosis in pancreatic cancer cells
Doaa M. Ali et al.
CELL DEATH DISCOVERY (2019)
Phagophores evolve from recycling endosomes
Claudia Puri et al.
AUTOPHAGY (2018)
Rapamycin treatment for amyotrophic lateral sclerosis Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
Jessica Mandrioli et al.
MEDICINE (2018)
Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells
Shariq S. Ansari et al.
CELL DEATH & DISEASE (2018)
Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction
He-Jin Lee et al.
CELL DEATH & DISEASE (2018)
Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity
Bassam Janji et al.
FRONTIERS IN IMMUNOLOGY (2018)
Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis
Anthony M. Lamattina et al.
CHEST (2018)
Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis
Martyna Bednarczyk et al.
Oncotarget (2018)
Origin of the Autophagosome Membrane in Mammals
Yun Wei et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial
Miranka Wirth et al.
CORTEX (2018)
An Observation of the Role of Autophagy in Patients with Endometriosis of Different Stages during Secretory Phase and Proliferative Phase
Meng Li et al.
CURRENT GENE THERAPY (2018)
A Critical Role of Autophagy in Regulating Microglia Polarization in Neurodegeneration
Meng-meng Jin et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Autophagy pathway: Cellular and molecular mechanisms
Li Yu et al.
AUTOPHAGY (2018)
Autophagy-from molecular mechanisms to clinical relevance
Monika Lippai et al.
CELL BIOLOGY AND TOXICOLOGY (2017)
Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action - a short report
Shariq S. Ansari et al.
CELLULAR ONCOLOGY (2017)
mTORC1 as the main gateway to autophagy
Yoana Rabanal-Ruiz et al.
SIGNALLING MECHANISMS IN AUTOPHAGY (2017)
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials
Martin D. Berger et al.
EUROPEAN JOURNAL OF CANCER (2017)
188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
Chia-Ming Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Autophagy Roles in the Modulation of DNA Repair Pathways
Luciana R. Gomes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment
Go J. Yoshida
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
Angela Alistar et al.
LANCET ONCOLOGY (2017)
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Autophagy Receptors and Neurodegenerative Diseases
Zhiqiang Deng et al.
TRENDS IN CELL BIOLOGY (2017)
Induction of autophagy by spermidine is neuroprotective via inhibition of caspase 3-mediated Beclin 1 cleavage
Yi Yang et al.
CELL DEATH & DISEASE (2017)
Upregulation of cell cycle genes in head and neck cancer patients may be antagonized by erufosine's down regulation of cell cycle processes in OSCC cells
Shariq S. Ansari et al.
Oncotarget (2017)
Molecular Pathways Controlling Autophagy in Pancreatic Cancer
Maria New et al.
FRONTIERS IN ONCOLOGY (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
ER-plasma membrane contact sites contribute to autophagosome biogenesis by regulation of local PI3P synthesis
Anna Chiara Nascimbeni et al.
EMBO JOURNAL (2017)
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dan T. Vogl et al.
CLINICAL CANCER RESEARCH (2017)
PINC trial: Preventing invasive breast neoplasia with chloroquine
Virginia A. Espina et al.
CANCER RESEARCH (2017)
Autophagy and multidrug resistance in cancer
Ying-Jie Li et al.
CHINESE JOURNAL OF CANCER (2017)
Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis Results of a Phase I Clinical Trial
Souheil El-Chemaly et al.
CHEST (2017)
New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
Payam Peymani et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Cellular proteostasis: degradation of misfolded proteins by lysosomes
Matthew P. Jackson et al.
PROTEOSTASIS (2016)
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
Andrew J. Yee et al.
LANCET ONCOLOGY (2016)
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Michael S. Bonkowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Mystery solved: Trehalose kickstarts autophagy by blocking glucose transport
Pablo Mardones et al.
SCIENCE SIGNALING (2016)
Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer
Sukeshi Patel et al.
ONCOTARGET (2016)
AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy
Xi Wei et al.
ONCOTARGET (2016)
Mystery solved: Trehalose kickstarts autophagy by blocking glucose transport
Pablo Mardones et al.
SCIENCE SIGNALING (2016)
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
Brian A. Boone et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Cholesterol homeostasis and autophagic flux in perifosine-treated human hepatoblastoma HepG2 and glioblastoma U-87 MG cell lines
Pablo Rios-Marco et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Signaling pathways and mechanisms of hypoxia-induced autophagy in the animal cells
Yungyun Fang et al.
CELL BIOLOGY INTERNATIONAL (2015)
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi et al.
EMBO JOURNAL (2015)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients
Mau-Shin Chi et al.
ONCOTARGET (2015)
Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort
Kwan-Hwa Chi et al.
ONCOTARGET (2015)
Autophagy in colorectal cancer: An important switch from physiology to pathology
Florin Burada et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2015)
Oxidative stress and autophagy: the clash between damage and metabolic needs
G. Filomeni et al.
CELL DEATH AND DIFFERENTIATION (2015)
Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer
Arturo Loaiza-Bonilla et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Combined autophagy and HDAC inhibition A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors
Devalingam Mahalingam et al.
AUTOPHAGY (2014)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Combined MTOR and autophagy inhibition Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Combined autophagy and proteasome inhibition A phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma
Dan T. Vogl et al.
AUTOPHAGY (2014)
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Myrna R. Rosenfeld et al.
AUTOPHAGY (2014)
Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD+/SIRT1 Reduction
Evandro Fei Fang et al.
CELL (2014)
Chaperone-mediated autophagy: roles in disease and aging
Ana Maria Cuervo et al.
CELL RESEARCH (2014)
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin
Irene Brana et al.
INVESTIGATIONAL NEW DRUGS (2014)
Interactions between Autophagy Receptors and Ubiquitin-like Proteins Form the Molecular Basis for Selective Autophagy
Vladimir Rogov et al.
MOLECULAR CELL (2014)
Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines
Deyan Y. Yosifov et al.
LEUKEMIA RESEARCH (2014)
Cargo recognition and trafficking in selective autophagy
Alexandra Stolz et al.
NATURE CELL BIOLOGY (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
Differential effects of erufosine on proliferation, wound healing and apoptosis in colorectal cancer cell lines
Ferda Kaleagasioglu et al.
ONCOLOGY REPORTS (2014)
Reduced Expression of the Retinoblastoma Protein Shows That the Related Signaling Pathway Is Essential for Mediating the Antineoplastic Activity of Erufosine
Maya M. Zaharieva et al.
PLOS ONE (2014)
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma
Angelika Bilger et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C. Kao et al.
CELL DEATH & DISEASE (2014)
Anticancer mechanisms and clinical application of alkylphospholipids
Wim J. van Blitterswijk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
The Trans locator Protein Radioligand 18F-DPA-714 Monitors Antitumor Effect of Erufosine in a Rat 9L Intracranial Glioma Model
Ali R. Awde et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Autophagosomes form at ER-mitochondria contact sites
Maho Hamasaki et al.
NATURE (2013)
Amino acid signalling upstream of mTOR
Jenna L. Jewell et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
Luis L. Rojas-Puentes et al.
RADIATION ONCOLOGY (2013)
Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma
M. Reis-Sobreiro et al.
BLOOD CANCER JOURNAL (2013)
Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial
Harriet B. Eldredge et al.
JOURNAL OF RADIATION ONCOLOGY (2013)
Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro
Yin Tong et al.
ACTA PHARMACOLOGICA SINICA (2012)
Phase II study of sorafenib in patients with relapsed or refractory lymphoma
Anna Guidetti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma
Vaishali Kapoor et al.
CANCER LETTERS (2012)
Microautophagy: lesser-known self-eating
Wen-wen Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome
Rossitza Lazova et al.
CLINICAL CANCER RESEARCH (2012)
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
Kathrin Zitzmann et al.
ENDOCRINE-RELATED CANCER (2012)
Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins
Ilina K. Dineva et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Atg9 vesicles are an important membrane source during early steps of autophagosome formation
Hayashi Yamamoto et al.
JOURNAL OF CELL BIOLOGY (2012)
A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small-Cell Lung Cancer
Sarah B. Goldberg et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
Noor Gammoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine
Weili Sun et al.
ONCOTARGETS AND THERAPY (2012)
Microautophagy in mammalian cells Revisiting a 40-year-old conundrum
Dalibor Mijaljica et al.
AUTOPHAGY (2011)
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity
Deyan Y. Yosifov et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cells
Rebecca G. Bagley et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Enhancing perifosine's anticancer efficacy by preventing autophagy
Shi-Yong Sun
AUTOPHAGY (2010)
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
Aadra P. Bhatt et al.
BLOOD (2010)
Mitochondria Supply Membranes for Autophagosome Biogenesis during Starvation
Dale W. Hailey et al.
CELL (2010)
mTOR regulation of autophagy
Chang Hwa Jung et al.
FEBS LETTERS (2010)
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound-Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
Diana Cirstea et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms
A. M. Martelli et al.
LEUKEMIA (2010)
Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathway
Sonja Katharina Koenigs et al.
LEUKEMIA RESEARCH (2010)
Plasma membrane contributes to the formation of pre-autophagosomal structures
Brinda Ravikumar et al.
NATURE CELL BIOLOGY (2010)
The origin of the autophagosomal membrane
Sharon A. Tooze et al.
NATURE CELL BIOLOGY (2010)
The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation
Justine Rudner et al.
RADIATION ONCOLOGY (2010)
Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
M. L. Marino et al.
CELL DEATH & DISEASE (2010)
Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy
Lei Fu et al.
CANCER RESEARCH (2009)
Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors
Camillo Porta et al.
JOURNAL OF UROLOGY (2009)
A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation
Mitsuko Hayashi-Nishino et al.
NATURE CELL BIOLOGY (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Anticancer alkylphospholipids: Mechanisms of action, cellular sensitivity and resistance, and clinical prospects
Wim J. van Blitterswijk et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane
Urmi Bandyopadhyay et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
In Hye Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs
Michael Fiegl et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
LAMP proteins are required for fusion of lysosomes with phagosomes
Kassidy K. Huynh et al.
EMBO JOURNAL (2007)
Adding chloroquine to conventional treatment for glioblastoma multiforme -: A randomized, double-blind, placebo-controlled trial
J Sotelo et al.
ANNALS OF INTERNAL MEDICINE (2006)
Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo
H Momota et al.
CANCER RESEARCH (2005)
A unified nomenclature for yeast autophagy-related genes
DJ Klionsky et al.
DEVELOPMENTAL CELL (2003)
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway
GA Ruiter et al.
ANTI-CANCER DRUGS (2003)
Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells
MC Georgieva et al.
CANCER LETTERS (2002)
Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells
A Petiot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
